Byotrol Share Discussion Threads

[sikhthetech] 01/10/2020 10:01

Both TLY & Byot have their yr end 31st March. TLY has a lower mcap.

TLY managed to publish their audited accounts in July, whereas Byot still haven't. No H1 figures rns from Byot, this morning either.

TLY have seen significant growth over the past 4 yrs. £106m revenue compared to Byot's £6m.



TLY:
Over the past 4 yrs TLY has grown significantly as can be seen from their results. This was achieved as part of their Add and Build strategy.


period revenue, cash, profit/loss
2015 £0.6m, £0.4m, £0.4m
2016 £4m, £1m, £1.4m
2017 £21.3m, £11.3m, £5.6m
2018 £42m, £10.2m, £0.2m
2019 £78m, £7.5m, £1.1m
2020 £105m, £8.9m, £4m

Gross margins up
already paying dividends.

[1gw] 01/10/2020 10:00

Did you really not watch it sikhthetech? As you know they couldn't really have released market-sensitive figures last night unless they had RNS'd them first.

[sikhthetech] 01/10/2020 09:55

not surprising is it, 1gw...
you and your mates buying then to make it look like there's interest.
;-)

Any H1 figures given they had the presentation at end of H1?

[1gw] 01/10/2020 09:55

Nice to see yesterday's strong presentation being rewarded with a good move higher in the share price this morning.

[sikhthetech] 01/10/2020 09:53

As their presentation was at the end of H1, you would have thought they would have provided some H1 figures. Cash, revenues...

So how much revenue did they receive during H1? How much cash have they in the bank?

[football] 30/9/2020 23:05

But there is only one at Boots that has the Boots and Byotrol on the same bottle

[a.fewbob] 30/9/2020 22:20

Lol!!

Sickinthehead is only on here because he’s sick in the head!!

The guy is bitter beyond belief. He obviously is a broke little peasant.

[wisecat2] 30/9/2020 22:16

That was an excellent presentation by David Traynor on the company The presentation and Q&A are available on the IMC website.

[wisecat2] 30/9/2020 22:13

at what price does sickinthehead have a nervous breakdown. 10p 15p or 20p

In the next 12 months you will be able to switch out of byotrol into Totally at the same price.

[a.fewbob] 30/9/2020 21:45

MONEY MONEY MONEY!!

But none for sick in the head because he’s a peasant.

[sikhthetech] 30/9/2020 21:43

1gw,

I'm saying other companies have adapted and come into the market. Are you saying CIF is fake or Nemesis alcohol free sanitiser at Boots is fake???? Really??



Tstl stated the position perfectly regarding tech and commercial success.


"The challenge we face with our partner Byotrol is essentially one of marketing communication: messaging. Today, UK hospitals use Jet because it is a high-performance, fast-acting biocide, effective against bacterial spores and compliant with every European legal requirement for disinfectants within one standard contact time of 1 minute, that is easy and convenient to use, and priced competitively to
pre-wetted wipes incorporating far less effective disinfectant chemistries."

As stated before, hospitals are already using effective cleaning products. Why would they want to change to test something else whilst in the middle of a pandemic?


"The intermediate level disinfectant formulation that has also been licensed from Byotrol will sit in one or more of the Cache Collection SKU’s, alongside other formulation offers that come from our own stable of non-CLO2 chemistries. The Byotrol intermediate level formulation is very well-documented and supported by their technical team. "

Byot formulation is just one of their offerings, competing against their own formulations. Which do you think will be priority to sell?


"We are enthusiastic for the combinatorial proposition but it is important that we set expectations sensibly (we follow with interest the excitable dialogue on the share chat rooms): this is not a gamechanging technological advance for Tristel plc. The grounded truth is that with our partner Byotrol we have created something unique from a chemistry perspective"
" The commercial success of that proposition will take a long time to
determine."

So it's unique from a chemistry perspective but don't know whether it's going to be a commercial success for a very long time. Long after Covid is history.

[1gw] 30/9/2020 21:19

Suggest you listen to the presentation if you can sikhthetech and listen to what they have to say about their technology, regulatory change and barriers to entry.

[sikhthetech] 30/9/2020 21:10

apart from Cif anti bacterial for £2 for a 700ml bottle,

Boots also sell other alcohol free products... again backing up my opinion that other companies will adapt and enter the market.







Amazon -
Zoono alcohol free sanitiser..

[tradertrev] 30/9/2020 21:04

I think it's probably safe now for everyone to filter sick in the head. No-one of any investment experience would take notice of what he writes, whether corrected by others or not. A cursory review of posts on this BB would make it abundantly clear he is unhinged and if anyone was to follow his line of thinking, more fool them.
I doubt he can damage the company now so best if he's ignored completely.
With no reaction to any of his posts he will quickly go away and annoy another bunch of people.

[sikhthetech] 30/9/2020 20:50

1gw

"if coronavirus cases continue to grow why wouldn't the sales continue at the £1m/month sort of level, especially if the supply chain is working better?"


Because during the early stages of Covid, Feb- June, everyone was buying whatever they could and there was a shortage - remember governments bought whatever they could from anywhere in the world. There weren't many suppliers around. Come June, July, other suppliers appeared and there wasn't such a shortage. Supply chains are now prepared for a 2nd wave.

Other companies have adapted and now there isn't such a shortage.

Also in the early stages, everyone was scared, using hand sanitiser, cleaning products etc..
Now office workers have been told to work from home. There's thousands of people
out on the streets, who don't care anymore. Why do people at home need sanitiser. Therefore, there's lower demand for sanitiser and specialist cleaning products.


Companies have adapted...
Cif anti bacterial, kills coronavirus... 700ml bottle for only £2.. I assume you've heard of CIF, it is a major brand...lol

[sikhthetech] 30/9/2020 20:39

1gw,
"I didn't put any numbers on the royalty"

You put a £'m' next to all the royalty figures which suggested to readers £millions.... so £1m would be your minimum.

and then you said 'SOME maybe k'.
So now you changed your mind. You now accept you were misleading everyone???


1gw14 May '20 - 17:37 - 5918 of 5960
2.000 6 1
Just as a reminder of the building blocks for this year:

£12m product sales (annual based on Mar-May run rate)
£ m royalty/minimum guaranteed payment Americas byotrol24
£ m royalty/minimum guaranteed payment SC Johnson Invirtu
£ m royalty/minimum guaranteed payment Tristel/Cache
£ m royalty/minimum guaranteed payment Solvay Actizone
£ m royalty Tristel new formulation (+ any increase in actizone supply sales over Apr-May rate)

Now some of the £m may be £k this year, but it seems to me byotrol is putting together an impressive portfolio of licence deals. And even so you could argue it is only just getting started: how many more deals can it do like the Tristel/Cache one to license non-core technologies to companies whose products are under regulatory threat? how many more geographies could it license byotrol24 in? can it license Invirtu in various geographies, or will meaningful royalties come in from the US red cross deal if Advanced Hygienics can find funding for marketing and production?

[1gw] 30/9/2020 20:02

Well, we have £6.5m product sales and it looks like £0.5m or so of license/royalty on the revenue side for 1H in the finnCap forecast (finnCap now at £0.65m license/royalty for the year assuming a further deal I think).

So on the product sales we seem to be running pretty well for the £12m revenue (which after all was just a run-rate calculation as I said), given 2H tends to be the bigger half anyway. finnCap are of course trying to be conservative about 2H, but if coronavirus cases continue to grow why wouldn't the sales continue at the £1m/month sort of level, especially if the supply chain is working better?

I didn't put any numbers on the royalty, I was just trying to show the building blocks, and of course it depends on whether you're looking at revenue, EBITDA or cash. The guaranteed payments are really most impressive when you look at the profit impact since you get the full contract-length impact and they are basically 100% margin.

But looking at that list in my earlier post, clearly the byotrol24 and SC Johnson lines are going to be there in all categories (revenue and EBITDA plus a smaller in-year cash contribution). The Tristel/Cache revenue and EBITDA from the guaranteed payments may have all been taken in FY20 given the £0.8m on the balance sheet so there may not be much of a contribution in FY21 unless sales exceed the minimum level - although there should be a cash contribution. Now that Solvay has launched Actizone there is the potential for further Solvay royalties this year (revenue and EBITDA) if they can exceed the minimum guaranteed amount - but in any case there should be a cash contribution. Things could get really interesting on Solvay royalty contribution next year (FY22). And on Tristel new formulation royalty I presume there is still a chance of some revenue, EBITDA and cash this year.

So I think that list still stands up pretty well as a shopping list of line items that will contribute to FY21 financials.

Happy to be corrected on any of this if you think it is inaccurate somehow. Did you even watch the presentation?

[sikhthetech] 30/9/2020 19:43

1gw

"There was a "lull" in summer purchasing activity at least in part because customers were aware that there was greater stock availability, and I presume some were by then being supplied on the orders placed earlier."

That's complete BS.

Repeat orders are down because their customers like homeandcleaning are selling less.


sikhthetech24 Sep '20 - 10:50 - 6856 of 6958 Edit
<...>
They had a lull in summer activity as expected and shown by lack of repeat orders which I mentioned in previous posts.


sikhthetech20 Aug '20 - 14:58 - 6719 of 6855 Edit
Repeat sales - Home and Cleaning on Ebay - Byotrol 5l bottles:

over 2 months, they now show as 228 sold, was 180 in June.
Slowing sales.

They sold 180 bottles during the 1st 4months/early stages of Covid, and now only 48 bottles over the last 2 months, less than 1 a day, since lockdown easing started.
Therefore sales at Home&Cleaning have gone down from avg 45 a month to 24 a month, down a half.
I would have expected an increase in sales after lockdown started to ease with shops, transport, offices started reopening.

[sikhthetech] 30/9/2020 19:39

H1 ends today.
They should have H1 figures, they should know revenues and cash in the bank, at least.

why not publish them today, at the same time as the Investor Presentation?

[sikhthetech] 30/9/2020 19:36

1gw
"The only guidance we have on 1H product sales is the £6.5m from finnCap which assumes roughly £1.0m/month July-September"

So they're not going to achieve the £17m you were suggesting, according to your model.
Told you it was just your usual ramping BS...
;-)


sikhthetech - 15 May 2020 - 12:49:49 - 5961 of 6957
1gw,

You claim to have attended the agm and spoken about US contracts and are now suggesting that Byot will make millions from Royalties this year.
Looking at your list, you're suggesting they will make £17m revenues from products and royalties.

Byot have only stated orders for Q1. Finncap have currently stated £9m, so neither are suggesting anything near your figures.


Advanced Hygienics (AH) has been a partner for THREE yrs.
Have they had meaningful royalties over the last 3 yrs? Royalties from an established deal would give a rough idea as to what can be expected. Was it £millions then?



1gw14 May '20 - 17:37 - 5918 of 5960
2.000 6 1
Just as a reminder of the building blocks for this year:

£12m product sales (annual based on Mar-May run rate)
£ m royalty/minimum guaranteed payment Americas byotrol24
£ m royalty/minimum guaranteed payment SC Johnson Invirtu
£ m royalty/minimum guaranteed payment Tristel/Cache
£ m royalty/minimum guaranteed payment Solvay Actizone
£ m royalty Tristel new formulation (+ any increase in actizone supply sales over Apr-May rate)

Now some of the £m may be £k this year, but it seems to me byotrol is putting together an impressive portfolio of licence deals. And even so you could argue it is only just getting started: how many more deals can it do like the Tristel/Cache one to license non-core technologies to companies whose products are under regulatory threat? how many more geographies could it license byotrol24 in? can it license Invirtu in various geographies, or will meaningful royalties come in from the US red cross deal if Advanced Hygienics can find funding for marketing and production?

[1gw] 30/9/2020 19:31

One thing that was very clear on the call was their focus on "profit" (adj EBITDA) rather than revenue. They were clearly, and justifiably, very proud of the successive FY21 adj EBITDA upgrades from their broker:

£1.1m 11th June
£1.5m 3rd August
£1.7m 24th September

And all compared to £0.3m actuals in FY20.

[1gw] 30/9/2020 19:24

What they actually said on the call is that the drop in the order book reflected greater stock availability. In the early days of the pandemic the company ran down its inventory position, given supply chain disruption, to meet demand and then had to tell potential customers that they couldn't supply immediately but they could take orders for future delivery when they had stock. Therefore the order book build reflected customers ordering further into the future than was normal. As the supply chain improved they were able to build stock back up which meant they could supply new demand more promptly and customers did not have to place orders to the same extent for future delivery. Therefore the order book size reduced, but the inventory was higher. There was a "lull" in summer purchasing activity at least in part because customers were aware that there was greater stock availability, and I presume some were by then being supplied on the orders placed earlier.

Now byotrol suggested that customers are starting to build back up their own stock levels to prepare for increased demand as coronavirus cases take off again (and to some extent to prepare for a possible "hard" brexit).

The only guidance we have on 1H product sales is the £6.5m from finnCap which assumes roughly £1.0m/month July-September i.e. no particularly significant change from the £1.1m/month reported for April-June. We may have to wait until late November/early December to get the interims which will show the actual number, and perhaps more significantly the revenue (and profit) booked from the licence and royalty deals.

Having said that, did Nic hint that there might be news before then on the basis that they might decide that the finnCap full-year guidance was too far off their current estimates? Presumably that is most likely to occur if they manage to complete a further multi-year license deal with guaranteed payments.

[sikhthetech] 30/9/2020 19:06

slicepie,
read company newsflow and "don’t rely on bb chat"
Agree. Like I've said many times, read the company newsflow.
Readers would then have known weeks in advance that there was a lull in orders, something which the company confirmed last week. Instead the bulls were repeadly suggesting trading was still at record levels.


sikhthetech - 06 Jul 2020 - 09:47:58 - 6311 of 6954
<...>

The May update FROM THE COMPANY:

Record levels in the 1st QTR, ie to June... then optimistic of high levels, not record levels for remainder of H1...


"As we start a new financial year, we are pleased to report that sales momentum remains strong. We expect to generate record sales in the first quarter of the year and are optimistic that high levels of demand will continue for the remainder of the first half at least.

Sales in March and April 2020 each exceeded GBP1m and we are expecting to show similarly strong performance in May. Our order book at the end of April stood at over GBP2m. The Group's supply chain is working well despite the global shortage of biocidal ingredients, exacerbated by unpredictable national lockdowns and border closures."




It's nice to have an investment decision proven right so conclusively BY EVENTS. READ THE COMPANY NEWSFLOW.